Skip to main content
Despite benefits, extended-interval pembro uptake remains low
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Despite benefits, extended-interval pembro uptake remains low
User login
Username
Password
Reset your password
Concept
Lead
score
Melanoma
1
1
Skin Cancer
0
0.92
Health Administration
0
0.58
Clinical Guidelines
0
0.49
Adverse Effects
0
0.29
Clinical Research
0
0.29
Comparative Effectiveness
0
0.29
Grant
0
0.29
Michigan
0
0.29
Pandemic
0
0.29
COVID-19
0
0.23
Healthcare and Medical Technology
0
0.23
Patient Safety
0
0.23
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
0.8
Pulmonary Medicine
0
0.9
Edit Tags